NCT07457138 · RECRUITING
Lombard Cohort of Brain Health Services
This Italian observational study is enrolling about 1,000 adults in the Lombardy region who have subjective memory concerns but no diagnosed cognitive impairment. Researchers will track blood-based Alzheimer's biomarkers, cognitive tests, and psychological well-being over five years. No phase applies here — this is not a drug trial but a long-term data-collection effort aimed at understanding who develops measurable Alzheimer's changes and when.
You may qualify if
- Adults (≥18 years)
- Diagnosis of SCD, FCD, or "well worried" individuals without objective cognitive impairment
- Evaluation at one of the Lombardy BHS
- Ability to provide written informed consent
You're excluded if
- Diagnosis of mild cognitive impairment or dementia at baseline visit
- Enrollment in another interventional study with an expected effect on cognition
- Pregnancy or breastfeeding
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-17